Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102787554 | 10278755 | 4 | F | 20130513 | 20150616 | 20140705 | 20150630 | EXP | JP-ALEXION PHARMACEUTICALS INC.-A201402297 | ALEXION | 0.00 | Y | 0.00000 | 20150630 | N | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102787554 | 10278755 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, QW | D | A90993D01 | 125166 | 600 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||
| 102787554 | 10278755 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | D | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 102787554 | 10278755 | 3 | C | PRIMOBOLAN /00044802/ | 2 | Oral | 20 MG, QD | D | 0 | 20 | MG | QD | |||||||
| 102787554 | 10278755 | 4 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 10 MG, QD | D | 0 | 10 | MG | QD | ||||||
| 102787554 | 10278755 | 5 | C | FLOMOX /01418603/ | 2 | Oral | 300 MG, QD | D | 0 | 300 | MG | QD | |||||||
| 102787554 | 10278755 | 6 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | Oral | 25 MG, PRN | D | 0 | 25 | MG | /yr |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102787554 | 10278755 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 102787554 | 10278755 | 3 | Paroxysmal nocturnal haemoglobinuria |
| 102787554 | 10278755 | 4 | Product used for unknown indication |
| 102787554 | 10278755 | 5 | Product used for unknown indication |
| 102787554 | 10278755 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102787554 | 10278755 | OT |
| 102787554 | 10278755 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102787554 | 10278755 | Bile duct stone | |
| 102787554 | 10278755 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102787554 | 10278755 | 1 | 20110610 | 0 | ||
| 102787554 | 10278755 | 2 | 20110708 | 0 | ||
| 102787554 | 10278755 | 3 | 20120707 | 20130911 | 0 | |
| 102787554 | 10278755 | 4 | 20130430 | 20130911 | 0 | |
| 102787554 | 10278755 | 5 | 20130509 | 20130515 | 0 | |
| 102787554 | 10278755 | 6 | 20130509 | 20130521 | 0 |